R6H4 Pep-LNP is a state-of-the-art peptide-functionalized lipid nanoparticle (LNP), designed for efficient targeted delivery of therapeutic cargoes such as siRNA, mRNA, DNA, small molecule drugs, and RNA-guided gene editing systems, particularly in acidic microenvironments like those found in tumors. Engineered with the R6H4 peptide, a pH-responsive cell-penetrating peptide composed of 6 arginine and 4 histidine residues, this LNP exhibits enhanced cellular uptake and endosomal escape within acidic conditions, enabling selective delivery of its cargo into tumor cells. Our LNP is prepared using DSPE-PEG-R6H4 and a variety of optional lipid formulations including DLin-MC3-DMA, LP-01, ALC-0315, SM102, and others. These formulations are carefully selected to ensure the LNP has uniform particle size, high encapsulation efficiency, stability, and targeted delivery. Applications of R6H4 Pep-LNP include research in targeted cancer therapy, pH-dependent drug release systems, enhancing nucleic acid delivery efficiency in tumors, and studying intracellular trafficking in acidic cellular compartments. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear AllInquiry
For Research Use Only. Not for Diagnostic or Treatment Applications.